Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC X-376 | 1365267-27-1 | 98.1% | 547.41 g·mol⁻¹ | C25H25Cl2FN6O3 | 10 MG
SDP

Catalog No. 5000289182
Encompass_Preferred

X-376 is a small-molecule tyrosine kinase inhibitor that potently targets anaplastic lymphoma kinase (ALK) and shows inhibitory activity against MET. It is supplied as a powder for preclinical research use and is suitable for cellular and in vivo studies of ALK-driven tumors.

  • Potent ALK inhibition (IC50 0.61 nM).
  • MET inhibitory activity (IC50 0.69 nM).
  • Suitable for preclinical cellular and in vivo research.
  • Supplied as a powder with recommended cold storage for stability.
  • Molecular weight 547.41 g·mol⁻¹; formula C25H25Cl2FN6O3.

Catalog No. 50-002-89182 Supplier Medchemexpress LLC Supplier No. HY1659010MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

X-376 is a small-molecule tyrosine kinase inhibitor that potently targets anaplastic lymphoma kinase (ALK) and shows inhibitory activity against MET. It is supplied as a powder for preclinical research use and is suitable for cellular and in vivo studies of ALK-driven tumors.

  • Potent ALK inhibition (IC50 0.61 nM).
  • MET inhibitory activity (IC50 0.69 nM).
  • Suitable for preclinical cellular and in vivo research.
  • Supplied as a powder with recommended cold storage for stability.
  • Molecular weight 547.41 g·mol⁻¹; formula C25H25Cl2FN6O3.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.